touchLearning Activities
Education, Conference Coverage and Articles
Dr Kamilė Čerlinskaitė-Bajorė is a cardiologist and touchCARDIO Future Leader 2026. In this interview, she discusses her journey into cardiology and heart failure, the mentors who have shaped her career, the challenges of caring for complex patients, and the importance of resilience and support from colleagues. She also shares her enthusiasm for advances in heart failure treatment and emerging research into heart failure with preserved ejection fraction.
Meet the cardiologists shaping the future of the specialty. Our touchCARDIO Future Leaders 2026 are rising stars nominated by the cardiology community for their contributions to research, clinical practice and innovation. Discover the clinicians and researchers challenging convention, advancing care and driving progress across cardiology.
Dr Aldostefano Porcari is a Consultant Cardiologist and touchCARDIO Future Leader 2026. In this interview, he discusses his journey into cardiology, the mentors and experiences that shaped his career, the clinical reasoning that drives his interest in complex cases, and the importance of understanding your strengths and finding a specialty that aligns with who you are.
Dr Maxime Caru is a pediatric exercise physiologist, researcher and touchCARDIO Future Leader 2026. In this interview, he discusses his journey into cardio-oncology, the mentors who shaped his career, the role of physical activity in reducing treatment-related cardiotoxicity in pediatric cancer survivors and his vision for integrating exercise and supportive care into standard pediatric oncology practice.
Dr Arunashis Sau is a cardiologist, electrophysiologist and touchCARDIO Future Leader 2026. In this interview, he discusses his journey into electrophysiology, the mentors who shaped his career, combining clinical training with research, and his work using artificial intelligence to unlock new insights from ECGs and other clinical data.
Dr Abhishek Chaturvedi is a cardiologist and touchCARDIO Future Leader 2026. In this interview, he discusses his journey into cardiology, the mentors and experiences that shaped his career, his passion for interventional cardiology and cardiovascular research, and the importance of combining clinical excellence, scientific discovery and global health initiatives to improve patient outcomes.
Dr Alfredo Caturano is an Assistant Professor of Internal Medicine and touchCARDIO Future Leader 2026. In this interview, he discusses his journey into cardiovascular and cardiometabolic medicine, the mentors who shaped his career, the challenges and rewards of clinical research, and the evolving links between diabetes, obesity and cardiovascular disease, as well as his vision for more personalised approaches to cardiometabolic care.
Dr Faisal Rahman is an interventional structural cardiologist and touchCARDIO Future Leader 2026. In this interview, he discusses his journey into cardiology, the mentors and role models who shaped his career, the rewards of caring for complex patients and developing trainees, and his vision for advancing cardiogenic shock, structural heart disease, research and education.
Dr Ushasi Saraswati is a physician specialising in cardiovascular medicine and touchCARDIO Future Leader 2026. In this interview, she discusses her journey into cardiology, the mentors who shaped her approach to medicine, the rewarding experience of caring for a patient with a complex diagnosis, and the importance of combining scientific curiosity and clinical expertise with compassion, clear communication and a commitment to patient-centred care.
Dr Vijay Shyam-Sundar is a cardiologist and touchCARDIO Future Leader 2026. In this interview, he discusses his journey into cardiology and clinical academia, the mentors who shaped his career, the challenges of research funding, and his work developing artificial intelligence to improve cardiovascular care, as well as his vision for the safe, explainable and effective use of AI in clinical practice.
ABLATE versus PACE: Pacemaker strategy reduces clinically relevant events in older patients with persistent atrial fibrillation Randomised trial shows substantially fewer hospitalisations and repeat interventions than pulmonary vein isolation. The benefit was partly offset by more heart failure events and ...
Immediate 14-day ambulatory ECG monitoring did not significantly reduce recurrent syncope at 1 year in the ASPIRED trial, but it more than doubled the detection of clinically significant arrhythmias and enabled earlier diagnosis and treatment. Following the presentation, Prof. Matthew Reed, from the Usher Institute, University of Edinburgh, and the Emergency Medicine Research Group Edinburgh, spoke about the origins of ASPIRED, the importance of earlier investigation for patients with syncope, and how this approach might be incorporated into routine care.
The PRESC1SE-MI trial found that a 0/1-hour pathway for assessing patients with suspected myocardial infarction was non-inferior to a more conservative 0/3-hour pathway for safety, but did not reduce the time patients spent in the emergency department.
Dr Jonathan Piccini discusses rhythm control in patients with atrial fibrillation and heart failure with preserved ejection fraction, the growing role of catheter ablation, and the evidence still needed to define its impact on cardiovascular outcomes.
At ESC Congress 2026, Dr Rami Abu Fanne (Hillel Yaffe Medical Center and Hadassah Medical Center, The Hebrew University of Jerusalem) presented an analysis exploring whether baseline vitamin D levels were associated with metabolic response to semaglutide in people with type 2 diabetes. The study included 5,300 adults and found that higher baseline vitamin D levels were associated with greater improvements in glycemic control and BMI after 12 months of treatment, although no association was observed with lipid outcomes. Dr Abu Fanne spoke to touchCARDIO about the findings and the questions they raise for future research.
The European Society of Cardiology (ESC) has published its first dedicated clinical practice guidelines on cardiac rehabilitation, calling for rehabilitation to be considered a core component of care across a broader range of cardiovascular conditions. Published in the European Heart ...
Prof. Thomas Thum discusses Phase II findings from the HF-REVERT study, what they suggest about patient selection for RNA-based therapies, and how these approaches could offer new ways to treat heart failure.
touchCARDIO
Register Now!
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
- Save your progress for video
- Keep track of your CME credits
- Add personalised learning notes
- Receive updates from course leaders and faculty
- Be the first to hear about new and exciting interactive learning opportunities
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
